SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities
JAMA
.
2021 Mar 16;325(11):1037-1038.
doi: 10.1001/jama.2021.2294.
Authors
Rochelle P Walensky
1
,
Henry T Walke
1
,
Anthony S Fauci
2
Affiliations
1
Centers for Disease Control and Prevention, Atlanta, Georgia.
2
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
PMID:
33595644
PMCID:
PMC9009864
DOI:
10.1001/jama.2021.2294
No abstract available
MeSH terms
COVID-19 / virology*
COVID-19 Vaccines*
Humans
SARS-CoV-2 / genetics*
United States
Substances
COVID-19 Vaccines
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States